Our extensive gene expression dataset generated on rodent models of AD pathology is well powered to identify transcriptional variation associated with mutations in MAPT and APP and the progressive changes in gene expression accompanying the development of AD pathology in TG mice (Figure S1C). This evidence concerns the gene MAPT and Alzheimer disease.